MicroTech Medical (Hangzhou) Co Ltd
02235
Company Profile
Business description
MicroTech Medical (Hangzhou) Co Ltd is focused on diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve the diabetes management in China and globally. The Group operates in a large and fast-growing diabetes monitoring, treatment and management market in China and globally with unmet clinical needs. The company derives a majority of its revenue from China.
Contact
No. 108 Liuze Street, Cangqian Street
Yuhang District
Zhejiang Province
Hangzhou
CHNT: +86 4000831811
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
664
Stocks News & Analysis
stocks
ASX share undervalued as margins expected to rebound
This ASX share remains overlooked despite a strong outlook.
stocks
Cheap retail REIT with an attractive yield
Lower consumer spending unlikely to buckle this retail REIT.
stocks
Expanding store network for ASX listed retailer
Sales growth but lack of margin expansion due to competition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,185.90 | 70.20 | 0.77% |
| CAC 40 | 8,418.93 | 28.34 | -0.34% |
| DAX 40 | 24,888.81 | 21.60 | -0.09% |
| Dow JONES (US) | 52,145.54 | 145.87 | 0.28% |
| FTSE 100 | 10,487.31 | 6.90 | -0.07% |
| HKSE | 24,312.16 | 181.79 | -0.74% |
| NASDAQ | 26,303.51 | 72.83 | -0.28% |
| Nikkei 225 | 69,902.25 | 497.75 | 0.72% |
| NZX 50 Index | 13,392.98 | 33.15 | -0.25% |
| S&P 500 | 7,503.25 | 8.10 | -0.11% |
| S&P/ASX 200 | 8,966.30 | 65.50 | 0.74% |
| SSE Composite Index | 4,108.08 | 16.18 | 0.40% |